We previously documented that liver-derived hepatoma cells express high levels of tumor/cancer stem cell (CSC) markers such as Myc, CD133, α-fetoprotein and doublecortin-like kinase (DCLK1, also called DCAMKL-1) in response to HCV replication [20]. This evidence concerns the gene DCLK1 and cancer.